Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer

Published:2016-04-27 Issue:1 Volume:11 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Dinh Tru-Khang T.,Fendler Wojciech,Chałubińska-Fendler Justyna,Acharya Sanket S.,O’Leary Colin,Deraska Peter V.,D’Andrea Alan D.,Chowdhury Dipanjan,Kozono David

Funder

Howard Hughes Medical Institute

Narodowe Centrum Nauki

Fundacja na rzecz Nauki Polskiej

Department of Radiation Oncology, Dana-Farber Cancer Institute

LUNGevity Foundation

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13014-016-0636-4.pdf

Reference48 articles.

1. Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA, Diekemper R, Detterbeck FC, Arenberg DA. CHEST Supplement. Chest. 2013;143(5):e314S–40.

2. Garg S, Gielda BT, Kiel K, Turian JV, Fidler MJ, Batus M, Bonomi P, Sher DJ. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy. Pract Radiat Oncol. 2014;4(5):342–8.

3. van Meerbeeck JP, Kramer GWPM, Van Schil PEY, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, et al. Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer. J Natl Cancer Inst. 2007;99(6):442–50.

4. Albain KS, Swann RS, Rusch VW, Turrisi AT, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374(9687):379–86.

5. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187–99.

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radio-miRs: a comprehensive view of radioresistance-related microRNAs;GENETICS;2024-07-04

2. Non‐coding RNAs and their potential exploitation in cancer therapy‐related cardiotoxicity;British Journal of Pharmacology;2024-05-27

3. The Molecular Mechanisms in Senescent Cells Induced by Natural Aging and Ionizing Radiation;Cells;2024-03-21

4. microRNA blood signature for localized radiation injury;Scientific Reports;2024-02-01

5. Extracellular Vesicles and Exosomes: Novel Insights and Perspectives on Lung Cancer from Early Detection to Targeted Treatment;Biomedicines;2024-01-07